From our site in Charles City, Iowa, USA, we develop and manufacture small molecule APIs, fine chemicals and intermediates for a wide range of applications.
Home to a team of more than 350 employees, the site is comprised of four large scale commercial cGMP production plants, as well as a cGMP pilot plant and cGMP kilo laboratory.
From our Charles City facility, we currently produce more than 40 APIs per year across our multi-purpose production units.
Our site is also equipped to handle controlled substances, with potent compound development, manufacturing, drying and packaging capabilities.
The facility is one of a limited number to be authorized by the Drug Enforcement Administration (DEA) to import narcotic raw materials at commercial scale.